Description

Ofloxacin (Ofloxacin) Solution for Infusions 0.2% 100 ml Vial

Ingredients

Ofloxacin (Ofloxacin) solution for infusions contains 0.2% of ofloxacin as the active ingredient.

Dosage

The recommended dosage of Ofloxacin solution for infusions is determined by the prescribing healthcare provider based on the specific condition being treated. It is typically administered intravenously over a specified period.

Indications

Ofloxacin solution for infusions is indicated for the treatment of various bacterial infections, including urinary tract infections, respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections.

Contraindications

Do not use Ofloxacin solution for infusions if you have a history of hypersensitivity to ofloxacin or any other quinolone antibiotics. It is important to consult with a healthcare provider before starting treatment.

Directions

Administer Ofloxacin solution for infusions as directed by a healthcare professional. It is important to follow the recommended dosage and infusion rate to ensure the effectiveness of the treatment.

Scientific Evidence

Ofloxacin, the active ingredient in Ofloxacin solution for infusions, is a fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Studies have shown that ofloxacin is effective against a wide range of gram-negative and gram-positive bacteria, making it a valuable option for the treatment of various infections.

Additional Information

Ofloxacin solution for infusions is well-tolerated in most patients, with common side effects including nausea, diarrhea, and headache. It is important to complete the full course of treatment as prescribed to ensure the best possible outcome.

Pharmacologically, Ofloxacin works by inhibiting the bacterial DNA gyrase enzyme, which is essential for bacterial DNA replication. This action leads to the disruption of bacterial cell division and ultimately the death of the bacteria. The high efficacy and broad spectrum of activity of Ofloxacin make it a valuable option in the treatment of various bacterial infections.

Clinical trials have demonstrated the effectiveness of Ofloxacin in the treatment of complicated urinary tract infections, community-acquired pneumonia, and skin and soft tissue infections. Comparative studies have shown that Ofloxacin is as effective as other fluoroquinolone antibiotics in treating these infections, with a favorable safety profile.